BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Cerilliant
Healthtrust
Julphar
Cantor Fitzgerald
Johnson and Johnson
Chubb
Mallinckrodt
Harvard Business School
AstraZeneca

Generated: January 21, 2018

DrugPatentWatch Database Preview

BICILLIN L-A Drug Profile

« Back to Dashboard

Which patents cover Bicillin L-a, and what generic alternatives are available?

Bicillin L-a is a drug marketed by King Pharms Llc and Wyeth Ayerst and is included in two NDAs.

The generic ingredient in BICILLIN L-A is penicillin g benzathine. There are eighty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the penicillin g benzathine profile page.
Drug patent expirations by year for BICILLIN L-A
Pharmacology for BICILLIN L-A
Medical Subject Heading (MeSH) Categories for BICILLIN L-A

US Patents and Regulatory Information for BICILLIN L-A

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms Llc BICILLIN L-A penicillin g benzathine INJECTABLE;INJECTION 050141-003 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
King Pharms Llc BICILLIN L-A penicillin g benzathine INJECTABLE;INJECTION 050141-001 Approved Prior to Jan 1, 1982 BC RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Ayerst BICILLIN L-A penicillin g benzathine INJECTABLE;INJECTION 050131-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Cipla
Fuji
Accenture
Federal Trade Commission
Teva
Merck
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot